Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to ropivacaine for postoperative analgesia after gynecologic laparotomy
ChiCTR1900024392Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: VAS scale, nausea and vomiting and 1 more. Started Jul 2019; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR1900024392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024392.